These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 1298553

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Protection by blockers against human low density lipoprotein peroxidation induced by oxygen free radicals].
    Napoli C, Ambrosio G, Chiariello P, Palumbo G, Chiariello M.
    G Ital Cardiol; 1994 Apr; 24(4):361-6. PubMed ID: 7914499
    [Abstract] [Full Text] [Related]

  • 3. Calcium-channel blockers inhibit human low-density lipoprotein oxidation by oxygen radicals.
    Napoli C, Chiariello M, Palumbo G, Ambrosio G.
    Cardiovasc Drugs Ther; 1996 Sep; 10(4):417-24. PubMed ID: 8924055
    [Abstract] [Full Text] [Related]

  • 4. [Human low-density lipoproteins are peroxidized by free radicals via chain reactions triggered by the superoxide radical].
    Napoli C, Ambrosio G, Palumbo G, Elia PP, Chiariello M.
    Cardiologia; 1991 Jul; 36(7):527-32. PubMed ID: 1665102
    [Abstract] [Full Text] [Related]

  • 5. [The peroxidation of human glycosylated low-density lipoproteins is mediated by the superoxide radical: the protective effects of superoxide dismutase].
    Napoli C, Ambrosio G, Palumbo G, Chiariello P, Duilio C, Chiariello M.
    Cardiologia; 1994 May; 39(5):345-52. PubMed ID: 8087816
    [Abstract] [Full Text] [Related]

  • 6. Calcium antagonists increase the amount of mRNA for the low-density lipoprotein receptor in skin fibroblasts.
    Eckardt H, Filipovic I.
    Artery; 1991 May; 18(4):168-83. PubMed ID: 1651691
    [Abstract] [Full Text] [Related]

  • 7. Antiperoxidative actions of calcium antagonists and atherogenesis.
    Henry PD.
    J Cardiovasc Pharmacol; 1991 May; 18 Suppl 1():S6-10. PubMed ID: 1723459
    [Abstract] [Full Text] [Related]

  • 8. Dual Ca2+ requirement for optimal lipid peroxidation of low density lipoprotein by activated human monocytes.
    Li Q, Tallant A, Cathcart MK.
    J Clin Invest; 1993 Apr; 91(4):1499-506. PubMed ID: 8473496
    [Abstract] [Full Text] [Related]

  • 9. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans.
    Aviram M, Dornfeld L, Kaplan M, Coleman R, Gaitini D, Nitecki S, Hofman A, Rosenblat M, Volkova N, Presser D, Attias J, Hayek T, Fuhrman B.
    Drugs Exp Clin Res; 2002 Apr; 28(2-3):49-62. PubMed ID: 12224378
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The effect of Ca++ antagonists on cellular lipid metabolism].
    Schmitz G, Hankowitz J, Brennhausen B, Schmutte C.
    Arzneimittelforschung; 1990 Mar; 40(3A):366-72. PubMed ID: 2185766
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations.
    Fleckenstein-Grün G, Thimm F, Czirfuzs A, Matyas S, Frey M.
    J Cardiovasc Pharmacol; 1994 Mar; 24 Suppl 2():S75-84. PubMed ID: 7898099
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Platelet activation by low-density lipoprotein and serotonin: effects of calcium antagonists.
    Fetkovska N.
    J Cardiovasc Pharmacol; 1992 Mar; 19 Suppl 3():S25-8. PubMed ID: 1376830
    [Abstract] [Full Text] [Related]

  • 18. Differential effect of two calcium channel blockers--nifedipine and diltiazem--on atherogenesis in hypercholesterolemic hamster.
    Raicu M, Pojoga L, Simionescu N, Simionescu M.
    J Submicrosc Cytol Pathol; 1996 Apr; 28(2):265-75. PubMed ID: 8964051
    [Abstract] [Full Text] [Related]

  • 19. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ, Guérin M, Bruckert E.
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [Abstract] [Full Text] [Related]

  • 20. Role of alpha-tocopheroxyl radical in the initiation of lipid peroxidation in human low-density lipoprotein exposed to horse radish peroxidase.
    Witting PK, Upston JM, Stocker R.
    Biochemistry; 1997 Feb 11; 36(6):1251-8. PubMed ID: 9063873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.